Status:
NOT_YET_RECRUITING
Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial
Lead Sponsor:
Northwestern University
Conditions:
Sebaceous Hyperplasia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare treatment of sebaceous hyperplasia with pulsed dye laser (PDL) plus neodymium doped yttrium aluminum garnet laser (Nd:YAG) versus erbium doped yttrium aluminum ...
Eligibility Criteria
Inclusion
- ≥18 years of age
- Receiving cosmetic treatment for sebaceous hyperplasia
- In good general health as assessed by the investigator
- Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study
Exclusion
- Patient pregnant or nursing
- Patient with history of poor wound healing that would result in hypertrophic scar or keloid at the discretion of the physician
- Patient with recent sun exposure that would result in pigment changes at the discretion of the physician
- Subject unwilling to sign an IRB approved consent form
- Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04429607
Start Date
July 1 2025
End Date
December 1 2026
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Department of Dermatology
Chicago, Illinois, United States, 60611